These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

163 related articles for article (PubMed ID: 18479257)

  • 41. Th17-related cytokines in inflammatory bowel diseases: friends or foes?
    Monteleone I; Sarra M; Pallone F; Monteleone G
    Curr Mol Med; 2012 Jun; 12(5):592-7. PubMed ID: 22515978
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Anti-TNF antibody-induced psoriasiform skin lesions in patients with inflammatory bowel disease are characterised by interferon-γ-expressing Th1 cells and IL-17A/IL-22-expressing Th17 cells and respond to anti-IL-12/IL-23 antibody treatment.
    Tillack C; Ehmann LM; Friedrich M; Laubender RP; Papay P; Vogelsang H; Stallhofer J; Beigel F; Bedynek A; Wetzke M; Maier H; Koburger M; Wagner J; Glas J; Diegelmann J; Koglin S; Dombrowski Y; Schauber J; Wollenberg A; Brand S
    Gut; 2014 Apr; 63(4):567-77. PubMed ID: 23468464
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Autoimmune inflammation from the Th17 perspective.
    Furuzawa-Carballeda J; Vargas-Rojas MI; Cabral AR
    Autoimmun Rev; 2007 Jan; 6(3):169-75. PubMed ID: 17289553
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Role of intestinal subepithelial myofibroblasts in inflammation and regenerative response in the gut.
    Andoh A; Bamba S; Brittan M; Fujiyama Y; Wright NA
    Pharmacol Ther; 2007 Apr; 114(1):94-106. PubMed ID: 17328956
    [TBL] [Abstract][Full Text] [Related]  

  • 45. IL-23 and T(H)17-mediated inflammation in human allergic contact dermatitis.
    Larsen JM; Bonefeld CM; Poulsen SS; Geisler C; Skov L
    J Allergy Clin Immunol; 2009 Feb; 123(2):486-92. PubMed ID: 18986691
    [TBL] [Abstract][Full Text] [Related]  

  • 46. IL-17 and anti-bacterial immunity: protection versus tissue damage.
    Cooper AM
    Eur J Immunol; 2009 Mar; 39(3):649-52. PubMed ID: 19283706
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Interleukin-12 family members and type I interferons in Th17-mediated inflammatory disorders.
    Goriely S; Cavoy R; Goldman M
    Allergy; 2009 May; 64(5):702-9. PubMed ID: 19383026
    [TBL] [Abstract][Full Text] [Related]  

  • 48. IL-23 and autoimmunity: new insights into the pathogenesis of inflammatory bowel disease.
    Abraham C; Cho JH
    Annu Rev Med; 2009; 60():97-110. PubMed ID: 18976050
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Th9 lymphocytes and functions of interleukin 9 with the focus on IBD pathology.
    Matusiewicz K; Iwańczak B; Matusiewicz M
    Adv Med Sci; 2018 Sep; 63(2):278-284. PubMed ID: 29567622
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Lnc-ITSN1-2, Derived From RNA Sequencing, Correlates With Increased Disease Risk, Activity and Promotes CD4
    Nie J; Zhao Q
    Front Immunol; 2020; 11():852. PubMed ID: 32547537
    [No Abstract]   [Full Text] [Related]  

  • 51. IL-33 and the intestine: The good, the bad, and the inflammatory.
    Hodzic Z; Schill EM; Bolock AM; Good M
    Cytokine; 2017 Dec; 100():1-10. PubMed ID: 28687373
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Emergence of the Th17 pathway and its role in host defense.
    O'Quinn DB; Palmer MT; Lee YK; Weaver CT
    Adv Immunol; 2008; 99():115-63. PubMed ID: 19117534
    [TBL] [Abstract][Full Text] [Related]  

  • 53. The IL-23/IL-17 axis in inflammation.
    Iwakura Y; Ishigame H
    J Clin Invest; 2006 May; 116(5):1218-22. PubMed ID: 16670765
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Alteration of interleukin 4 production results in the inhibition of T helper type 2 cell-dominated inflammatory bowel disease in T cell receptor alpha chain-deficient mice.
    Iijima H; Takahashi I; Kishi D; Kim JK; Kawano S; Hori M; Kiyono H
    J Exp Med; 1999 Sep; 190(5):607-15. PubMed ID: 10477546
    [TBL] [Abstract][Full Text] [Related]  

  • 55. IL-23/IL-17 immune axis in Guillain Barré Syndrome: Exploring newer vistas for understanding pathobiology and therapeutic implications.
    Debnath M; Nagappa M; Murari G; Taly AB
    Cytokine; 2018 Mar; 103():77-82. PubMed ID: 29331587
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Role of miR-22 in intestinal mucosa tissues and peripheral blood CD4+ T cells of inflammatory bowel disease.
    Pei XF; Cao LL; Huang F; Qiao X; Yu J; Ye H; Xi CL; Zhou QC; Zhang GF; Gong ZL
    Pathol Res Pract; 2018 Aug; 214(8):1095-1104. PubMed ID: 29880327
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Biomedicine. Puzzling out the pains in the gut.
    Marx J
    Science; 2007 Jan; 315(5808):33-5. PubMed ID: 17204619
    [No Abstract]   [Full Text] [Related]  

  • 58. Role of type 2 immunity in intestinal inflammation.
    Bamias G; Cominelli F
    Curr Opin Gastroenterol; 2015 Nov; 31(6):471-6. PubMed ID: 26376478
    [TBL] [Abstract][Full Text] [Related]  

  • 59. IL-12-and IL-23 in health and disease.
    Croxford AL; Kulig P; Becher B
    Cytokine Growth Factor Rev; 2014 Aug; 25(4):415-21. PubMed ID: 25130295
    [TBL] [Abstract][Full Text] [Related]  

  • 60. The IL-17 cytokine family and their role in allergic inflammation.
    Wang YH; Liu YJ
    Curr Opin Immunol; 2008 Dec; 20(6):697-702. PubMed ID: 18832032
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.